Endothelial progenitor cell-derived conditioned medium mitigates chronic cerebral ischemic injury through macrophage migration inhibitory factor-activated AKT pathway

Ya-Wen Cheng,Ling-Yu Yang,Yi-Tzu Chen,Sheng-Che Chou,Kuo-Wei Chen,Yi-Hsing Chen,Chuan-Rou Deng,I-Chin Chen,Wan-Ju Chou,Chen-Chih Chang,Yong-Ren Chen,Hsiao-Lin Hwa,Kuo-Chuan Wang,Meng-Fai Kuo
DOI: https://doi.org/10.1186/s13287-024-04015-5
2024-11-19
Stem Cell Research & Therapy
Abstract:Chronic cerebral ischemia (CCI) is a significant health issue characterized by hypoperfusion due to damage or occlusion of the cerebral or carotid arteries. CCI may lead to progressive cognitive impairment that is considered as a prelude to neurodegenerative diseases, including dementia and Alzheimer's disease (AD). Endothelial progenitor cells (EPCs) have been implicated in vascular repair in ischemic cerebrovascular diseases, primarily by differentiating into endothelial cells (ECs) or through paracrine effects. However, the clinical transplantation of stem cell therapies remains limited. In this study, we investigated the effects of EPC-derived conditioned medium (EPC-CM) on the impaired vasculature and neurological function in a rodent model of CCI and the mechanism involved.
cell biology,medicine, research & experimental,cell & tissue engineering
What problem does this paper attempt to address?